Literature DB >> 20622723

Obstructive sleep apnea and immunity: relationship of lymphocyte count and apnea hypopnea index.

Amado X Freire1, Dipen Kadaria, Jaime F Avecillas, Luis C Murillo, Jose C Yataco.   

Abstract

OBJECTIVES: The impact of chronic poor quality sleep on immunity as seen in obstructive sleep apnea (OSA) has not been evaluated. We aim to explore the relationship between lymphocytes, neutrophil, and total leukocyte counts with severity stratified apnea hypopnea index (AHI) in patients with OSA.
METHODS: A retrospective review of 119 patients' medical records diagnosed with OSA from October 2005 to July 2006 was performed. Data collected included demographics, comorbidities, total leukocyte, neutrophil, and lymphocyte count, body mass index (BMI), AHI, and Epworth sleepiness scores (ESS). Three AHI strata were constructed: mild (5-14), moderate (15-29), and severe (>30). Data were fitted in a linear regression model on which lymphocyte counts were the dependent variable against age, BMI, and AHI. An interaction product was also explored (age*BMI). All tests were two-sided; a P < 0.05 was considered statistically significant. We used Statview Version 5.01 (SAS Institute, Inc., Cary, NC) for the analysis.
RESULTS: Our study showed a linear association among AHI and BMI (P = 0.0017), but did not show association between lymphocyte count with either BMI (P = 0.33) or AHI (P = 0.90). A negative association between lymphocytes and age (P = 0.02) that persisted after adjustments for BMI and AHI was found. An interaction product (age*AHI) was not associated with lymphocyte count (P = 0.87). No correlation was found between peripheral blood count (P = 0.29) or neutrophil counts (P = 0.38) and AHI.
CONCLUSION: We found OSA-induced sleep interruption not associated with lymphocyte, neutrophil, or peripheral blood cell count alterations. This information is useful for researchers evaluating the influence of sleep disruption on immunity.

Entities:  

Mesh:

Year:  2010        PMID: 20622723     DOI: 10.1097/SMJ.0b013e3181e6dabf

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  7 in total

1.  The association of hemocyte profile and obstructive sleep apnea.

Authors:  Zeqin Fan; Xiaoxia Lu; Hong Long; Taoping Li; Yanhong Zhang
Journal:  J Clin Lab Anal       Date:  2018-09-23       Impact factor: 2.352

2.  The Significance of the Relative Lymphocyte Count as an Independent Predictor of Cardiovascular Disease in Patients with Obstructive Sleep Apnea Syndrome.

Authors:  Vildan Altunayoglu Cakmak; Savas Ozsu; Ayhan Gulsoy; Ramazan Akpinar; Yilmaz Bulbul
Journal:  Med Princ Pract       Date:  2016-06-20       Impact factor: 1.927

Review 3.  Recognition and treatment of sleep-disordered breathing: an important component of chronic disease management.

Authors:  Peter C Farrell; Glenn Richards
Journal:  J Transl Med       Date:  2017-05-25       Impact factor: 5.531

4.  Cholinergic Markers and Cytokines in OSA Patients.

Authors:  Marcella Reale; Lucia Velluto; Marta Di Nicola; Chiara D'Angelo; Erica Costantini; Michele Marchioni; Gianluigi Cerroni; Biancamaria Guarnieri
Journal:  Int J Mol Sci       Date:  2020-05-05       Impact factor: 5.923

5.  Identification of Sleep Apnea Severity Based on Deep Learning from a Short-term Normal ECG.

Authors:  Erdenebayar Urtnasan; Jong Uk Park; Eun Yeon Joo; Kyoung Joung Lee
Journal:  J Korean Med Sci       Date:  2020-12-07       Impact factor: 2.153

6.  Can the complete blood count be used as a reliable screening tool for obstructive sleep apnea?

Authors:  Emer Cummins; Rida Waseem; Deween Piyasena; Chew Yin Wang; Colin Suen; Clodagh Ryan; Jean Wong; Meir Kryger; Frances Chung
Journal:  Sleep Breath       Date:  2021-06-29       Impact factor: 2.816

7.  The treg/th17 imbalance in patients with obstructive sleep apnoea syndrome.

Authors:  Jin Ye; Hui Liu; Gehua Zhang; Peng Li; Zhiyuan Wang; Shaotong Huang; Qintai Yang; Yuan Li
Journal:  Mediators Inflamm       Date:  2012-12-31       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.